Join With Us to Improve Lives

PhotoPharmics is a clinical-stage therapeutic device company developing next-generation treatments for addressing neurodegenerative disorders through the eyes. We have 30 years of experience in product innovation, clinical trials, and market development in photo-neuromodulation. We previously developed specialized solutions now widely used to regulate circadian rhythms for seasonal affective disorder, sleep disorders, anxiety, and depression (acquired by Philips-Respironics in 2007).

Our main focus is Parkinson’s, and we are extending our research into several other neurodegenerative diseases. We aim to make a clinically meaningful difference in patients’ lives by delivering safe and effective treatments. PhotoPharmics is privately held.

Video Overviews

Investor Inquiry

Want to help us make a meaningful difference in patients’ lives?  Complete the form below to connect with us. Or call us at +1 (801) 770-6960.